We are live on
!
Find out more
Creative Planning Portfolio holdings
AUM
$171B
1-Year Est. Return
24.68%
This Fund
S&P 500
This Quarter
Est. Return
-0.2%
1 Year Est. Return
+24.68%
3 Year Est. Return
+62.17%
5 Year Est. Return
+55.89%
10 Year Est. Return
+171.9%
AUM
$147B
AUM Growth
+$7.72B
(+5.5%)
Cap. Flow
+$9.48B
Cap. Flow
% of AUM
6.43%
Top 10 Holdings %
Top 10 Hldgs %
41.95%
Holding
4,221
New
328
Increased
2,776
Reduced
891
Closed
131
Avg Time Held Equity + Options
16.9
quarters
Top 10 Avg Time Held Equity + Options
5.9
quarters
Top 20 Avg Time Held Equity + Options
16.1
quarters
Avg Time Held Equity only
16.9
quarters
Top 10 Avg Time Held Equity only
5.9
quarters
Top 20 Avg Time Held Equity only
16.1
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Short-Term Bond ETF
BSV
|
+$888M |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$700M |
| 3 |
State Street SPDR Portfolio Developed World ex-US ETF
SPDW
|
+$408M |
| 4 |
iShares Core US Aggregate Bond ETF
AGG
|
+$338M |
| 5 |
Vanguard Russell 1000 Value ETF
VONV
|
+$280M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$248M |
| 2 |
Schwab US Large- Cap ETF
SCHX
|
+$41.4M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$39.9M |
| 4 |
Schwab US Large-Cap Value ETF
SCHV
|
+$34.6M |
| 5 |
Schwab US Mid-Cap ETF
SCHM
|
+$32M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 75.77% |
| 2 | Technology | 8.02% |
| 3 | Financials | 3.7% |
| 4 | Industrials | 2.22% |
| 5 | Healthcare | 2.17% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3526
Enerpac Tool Group
EPAC
$1.8B
| $262K | ﹤0.01% |
+7,183
| New | +$285K |
2026 Q1
0 quarters
|
|
3527
Capital Group Core Balanced ETF
CGBL
$7.82B
| $262K | ﹤0.01% |
7,607
-4,785
| -39% | -$171K |
2025 Q2
3 quarters
|
|
3528
abrdn Healthcare Investors
HQH
$1.09B
| $261K | ﹤0.01% |
14,667
+4,549
| +45% | +$86K |
2025 Q3
2 quarters
|
|
3529
iShares Core Dividend ETF
DIVB
$2.05B
| $260K | ﹤0.01% |
+4,824
| New | +$265K |
2026 Q1
0 quarters
|
|
3530
VanEck Morningstar SMID Moat ETF
SMOT
$306M
| $260K | ﹤0.01% |
+7,389
| New | +$270K |
2026 Q1
0 quarters
|
|
3531
American Coastal Insurance
ACIC
$502M
| $260K | ﹤0.01% |
23,080
+4,388
| +23% | +$49.3K |
2025 Q3
2 quarters
|
|
3532
State Street SPDR US Large Cap Low Volatility Index ETF
LGLV
$1.14B
| $259K | ﹤0.01% |
+1,453
| New | +$265K |
2026 Q1
0 quarters
|
|
3533
PIMCO Corporate & Income Opportunity Fund
PTY
$2.39B
| $259K | ﹤0.01% |
21,437
-2,904
| -12% | -$37K |
2013 Q2
51 quarters
|
|
3534
Nuveen California AMT-Free Quality Municipal Income Fund
NKX
$595M
| $258K | ﹤0.01% |
21,722
-9,103
| -30% | -$116K |
2019 Q1
28 quarters
|
|
3535
Nuveen Preferred & Income Opportunities Fund
JPC
$2.57B
| $258K | ﹤0.01% |
34,277
+4,713
| +16% | +$38.1K |
2024 Q2
7 quarters
|
|
3536
DNOW Inc
DNOW
$2.78B
| $258K | ﹤0.01% |
21,680
-10,766
| -33% | -$146K |
2025 Q4
1 quarter
|
|
|
PKST
3537
DELISTED
Peakstone Realty Trust
PKST
| $258K | ﹤0.01% |
12,351
+1,086
| +10% | +$20.3K |
2023 Q2
11 quarters
|
|
3538
Summit Therapeutics
SMMT
$12.4B
| $258K | ﹤0.01% |
13,597
+786
| +6% | +$12.7K |
2024 Q2
7 quarters
|
|
3539
Franklin Disruptive Commerce ETF
BUYZ
$5.48M
| $258K | ﹤0.01% |
8,002
| – | – |
2024 Q4
5 quarters
|
|
3540
Vanguard Ultra-Short Treasury ETF
VGUS
$1.08B
| $257K | ﹤0.01% |
+3,402
| New | +$257K |
2026 Q1
0 quarters
|
|
3541
Ondas Inc
ONDS
$3.91B
| $257K | ﹤0.01% |
28,431
+6,917
| +32% | +$75.2K |
2025 Q3
2 quarters
|
|
3542
Orchid Island Capital
ORC
$999M
| $257K | ﹤0.01% |
36,523
+4,713
| +15% | +$35.6K |
2023 Q4
9 quarters
|
|
3543
BlackRock Enhanced Equity Dividend Trust
BDJ
$1.7B
| $256K | ﹤0.01% |
29,751
+4,393
| +17% | +$41K |
2025 Q4
1 quarter
|
|
3544
Distillate US Fundamental Stability & Value ETF
DSTL
$2.04B
| $256K | ﹤0.01% |
+4,428
| New | +$266K |
2026 Q1
0 quarters
|
|
3545
Viridian Therapeutics
VRDN
$2.06B
| $256K | ﹤0.01% |
13,101
+162
| +1% | +$4.81K |
2025 Q2
3 quarters
|
|
3546
DELISTED
Esperion Therapeutics
ESPR
| $256K | ﹤0.01% |
93,492
-23,875
| -20% | -$75.6K |
2025 Q3
2 quarters
|
|
|
SVC
3547
Service Properties Trust
SVC
$767M
| $256K | ﹤0.01% |
37,740
-13,847
| -27% | -$144K |
2015 Q3
42 quarters
|
|
3548
iShares MSCI USA Small-Cap ETF
MSML
$272M
| $255K | ﹤0.01% |
3,923
| – | – |
2024 Q2
7 quarters
|
|
3549
Trustmark
TRMK
$2.59B
| $255K | ﹤0.01% |
6,060
-2,789
| -32% | -$118K |
2025 Q3
2 quarters
|
|
3550
Franklin FTSE Switzerland ETF
FLSW
$82.7M
| $255K | ﹤0.01% |
+6,287
| New | +$266K |
2026 Q1
0 quarters
|
|
Similar funds
Creative Planning's Q1 2026 Portfolio in Review
As of Q1 2026, Creative Planning held 4,221 positions worth $147B, up 5.5% from $140B the previous quarter. Its ten largest holdings account for 42% of the portfolio.
Creative Planning deployed $9.48B of net new capital in Q1 2026, opening 328 new positions and adding to 2,776 existing holdings. Its largest new stake was Innovator US Equity Power Buffer ETF August: 270,134 shares worth $11.5M.
By sector, the portfolio is most concentrated in Miscellaneous at 76% of assets, down from 76% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Vanguard FTSE Developed Markets ETF, an estimated $248M trimmed.
- Creative Planning's largest Q1 2026 buy was Innovator US Equity Power Buffer ETF August: 270,134 shares worth $11.5M.
- Creative Planning added most to Vanguard Short-Term Bond ETF in Q1 2026, an estimated $888M increase.
- Creative Planning's biggest Q1 2026 reduction was Vanguard FTSE Developed Markets ETF, cutting an estimated $248M.
- Creative Planning fully exited CyberArk in Q1 2026, selling an estimated $9.29M.
- Creative Planning's ten largest holdings make up 42% of its $147B portfolio in Q1 2026.
- Creative Planning opened 328 new positions and closed 131 in Q1 2026.
- Creative Planning's portfolio value rose 5.5% quarter-over-quarter to $147B.
Based on Creative Planning's 13F filing for Q1 2026, filed 12 May 2026.